Bioinformatics
Genomics & Genetic Testing
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Visa sponsorship
A-rated
Sponsor licence
Skilled Worker +1
Visa route
0
Open roles in United Kingdom
In the register as Congenica LTD, Cambridge
Other sponsors in the same field
Alert me
UK Home Office · checked Nov 3, 2026 · Visa details by country
Overview
Congenica is a Cambridge company founded in 2014 that interprets genomic data for clinical diagnosis. Its software analyses whole genome sequences to identify disease causing variants and was adopted by the British hundred thousand genomes programme. The company works with health systems and pharmaceutical partners internationally.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

CICVia a fund

Parkwalk AdvisorsVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer Cambridge, United Kingdom - 3rd May 2022 - Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, a
Read more
Report
Congenica completes $50m series C funding round
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people's lives, is pleased to announce the completion of its Series C funding round,…
Read more
Report
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
Read more
Report
Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round
Read more
Report
Congenica closes B round
Congenica said April 27 that it closed a Series B round of funding. Additional investors include BGI Genomics, Healthlink Capital and Future Planet Capital. Congenica, of Cambridge, U.K., is a developer of clinical genomics software for inherited diseases
Read more
Report
SeqOne Genomics appoints Martin Dubuc as Chief Executive Officer
Martin Dubuc appointed as SeqOne Genomics CEO, Nicolas Philippe becomes President & CPSO to drive global clinical genomics expansion.
Read more
Report
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
The PAOLA-1/ENGOT-ov25 trial showed that maintenance olaparib plus bevacizumab increases survival of advanced ovarian cancer patients with homologous recombination deficiency (HRD).
Read more
Report
SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine
Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United Kingdom
HQ
10-50 est. staff
Financials
Total raised
$51.3M
Latest round
Venture - Series Unknown
Funding rounds
19
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2022 | — | Details |
| Grant | 2021 | $806k | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Series C | 2020 | $50M | Details |
| Venture - Series Unknown | 2020 | — | Details |
| Venture - Series Unknown | 2019 | — | Details |
| Venture - Series Unknown | 2019 | — | Details |
| Venture - Series Unknown | 2018 | — | Details |
| Grant | 2018 | $517k | Details |
| Venture - Series Unknown | 2018 | — | Details |
| Venture - Series Unknown | 2017 | — | Details |
| Series B | 2017 | — | Details |
| Venture - Series Unknown | 2017 | — | Details |
| Venture - Series Unknown | 2015 | — | Details |
| Venture - Series Unknown | 2015 | — | Details |
| Venture - Series Unknown | 2014 | — | Details |

Revvity
Oxford Nanopore Technologies
Basecamp Research
Genomics